-
1 . Academic Journal
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- 저자
- by Ahmann, Andrew J; Arora, Samir; Ball, Eric M; Calderon, Rafael B; Butuk, David J, et al.
- 소스
- In The Lancet 13 November 2021 398(10313):1811-1824
-
7 . Periodical
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- 저자
- by Del Prato, Stefano; Kahn, Steven E; Pavo, Imre; Weerakkody, Govinda J; Yang, Zhengyu, et al.
- 소스
- The Lancet; 20210101, Issue: Preprints